1.85 USD
▼-0.14-7.04%
盘后 1.87 +1.08%
2026-09-15
市值
$216.57M
市盈率
—
EPS
-0.24
股息率
—
52 周区间
0.88 – 2.34
成交量
1.17M
Beta
0.61
目标价
8.56
52W 低 0.8852W 高 2.34
价格走势
公司简介
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol fo...